Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

44.01
-0.5500-1.23%
Pre-market: 43.36-0.6500-1.48%04:56 EDT
Volume:6.58M
Turnover:291.64M
Market Cap:196.50B
PE:10.99
High:44.82
Open:44.60
Low:44.01
Close:44.56
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:0.69
T/O Rate:0.21%
Dividend:1.72
Dividend Rate:3.91%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.03
PE(LYR):12.16

Loading ...

Dow Jones Top Company Headlines at 7 am ET: Novo Nordisk Seeks Injunction Against Eli Lilly in Dispute over Weight-loss Ads | EU ...

Dow Jones
·
Jul 24

Novo Nordisk Seeks Preliminary Injunction Against Lilly Weight-loss Ads

Reuters
·
Jul 24

Novo Nordisk: Asked the Court to Preliminarily Halt Eli Lilly's Misleading Glp-1 Advertising Campaigns While Novo Nordisk’s Lawsuit Proceeds

THOMSON REUTERS
·
Jul 24

Novo Nordisk: Filed a Motion for a Preliminary Injunction in the United States District Court for the District of New Jersey

THOMSON REUTERS
·
Jul 24

Novo Nordisk A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jul 23

PRESS Digest-british Business - July 22

Reuters
·
Jul 22

PRESS Digest-financial Times - July 22

Reuters
·
Jul 22

Trump Announces Two-Year Zero Tariffs On Imported Generics From Aug. 1, 2026; Then 100% And 200% Hikes

MT Newswires Live
·
Jul 22

Moderately bullish activity in Novo Nordisk with shares down 0.51%

TIPRANKS
·
Jul 22

Sector Update: Healthcare

MT Newswires Live
·
Jul 22

Novo Nordisk’s AMAZE 13 Trial Adds Fresh Momentum to Its Obesity Pipeline

TIPRANKS
·
Jul 22

Top Midday Stories: 3M Shares Rise on Strong Guidance; Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising

MT Newswires Live
·
Jul 21

Eli Lilly on Novo Nordisk Lawsuit- "we Stand Firmly Behind Our Advertising"

THOMSON REUTERS
·
Jul 21

Eli Lilly Faces Lawsuit Over Weight-Loss Drug Ads! Accused By Novo Nordisk Of "Misleading Marketing"

Sector Pulse
·
Jul 21

U.S. Stocks on the Move-utz Brands, Tutor Perini, Tripadvisor

Reuters
·
Jul 21

Novo Nordisk Shares Dip 2% in Pre-Market Trading

Deep News
·
Jul 21

Novo Nordisk Shares Down 2% After Co Sues Lilly, Accusing it of False Advertising

THOMSON REUTERS
·
Jul 21

Eli Lilly Faces Legal Action from Novo Nordisk Over Alleged Misleading Weight-Loss Drug Advertisements

Stock News
·
Jul 21

Novo Nordisk Says Mismatched Diabetes Drug Ads Triggered Lawsuit Vs. Lilly

Dow Jones
·
Jul 21

Novo Nordisk files lawsuit against ‘misleading’ GLP-1 ads from Eli Lilly

TIPRANKS
·
Jul 21